nodes	percent_of_prediction	percent_of_DWPC	metapath
Butabarbital—Hypoxia—Gefitinib—lung cancer	0.0153	0.0353	CcSEcCtD
Butabarbital—Respiratory failure—Crizotinib—lung cancer	0.0109	0.0251	CcSEcCtD
Butabarbital—Respiratory failure—Pemetrexed—lung cancer	0.00996	0.023	CcSEcCtD
Butabarbital—Respiratory failure—Gefitinib—lung cancer	0.00989	0.0228	CcSEcCtD
Butabarbital—Hypoxia—Vinorelbine—lung cancer	0.0079	0.0182	CcSEcCtD
Butabarbital—Dermatitis exfoliative—Gefitinib—lung cancer	0.00747	0.0172	CcSEcCtD
Butabarbital—Hypoxia—Gemcitabine—lung cancer	0.00635	0.0146	CcSEcCtD
Butabarbital—Respiratory failure—Topotecan—lung cancer	0.00598	0.0138	CcSEcCtD
Butabarbital—Hepatocellular injury—Erlotinib—lung cancer	0.00581	0.0134	CcSEcCtD
Butabarbital—Bradycardia—Crizotinib—lung cancer	0.00547	0.0126	CcSEcCtD
Butabarbital—Respiratory failure—Vinorelbine—lung cancer	0.00511	0.0118	CcSEcCtD
Butabarbital—Liver injury—Cisplatin—lung cancer	0.00447	0.0103	CcSEcCtD
Butabarbital—Syncope—Crizotinib—lung cancer	0.00419	0.00967	CcSEcCtD
Butabarbital—Loss of consciousness—Crizotinib—lung cancer	0.00411	0.00948	CcSEcCtD
Butabarbital—Respiratory failure—Gemcitabine—lung cancer	0.00411	0.00947	CcSEcCtD
Butabarbital—Apnoea—Etoposide—lung cancer	0.00406	0.00937	CcSEcCtD
Butabarbital—Angioedema—Gefitinib—lung cancer	0.00388	0.00895	CcSEcCtD
Butabarbital—Syncope—Pemetrexed—lung cancer	0.00383	0.00884	CcSEcCtD
Butabarbital—Hepatocellular injury—Cisplatin—lung cancer	0.00376	0.00867	CcSEcCtD
Butabarbital—Loss of consciousness—Pemetrexed—lung cancer	0.00376	0.00866	CcSEcCtD
Butabarbital—Shock—Crizotinib—lung cancer	0.00375	0.00866	CcSEcCtD
Butabarbital—Respiratory failure—Paclitaxel—lung cancer	0.00344	0.00793	CcSEcCtD
Butabarbital—Shock—Pemetrexed—lung cancer	0.00343	0.00791	CcSEcCtD
Butabarbital—Shock—Gefitinib—lung cancer	0.00341	0.00786	CcSEcCtD
Butabarbital—Constipation—Crizotinib—lung cancer	0.00326	0.00753	CcSEcCtD
Butabarbital—Hypoxia—Methotrexate—lung cancer	0.00325	0.00749	CcSEcCtD
Butabarbital—Hypotension—Gefitinib—lung cancer	0.00324	0.00747	CcSEcCtD
Butabarbital—Dermatitis exfoliative—Irinotecan—lung cancer	0.00319	0.00735	CcSEcCtD
Butabarbital—Agitation—Teniposide—lung cancer	0.00318	0.00734	CcSEcCtD
Butabarbital—Body temperature increased—Crizotinib—lung cancer	0.00302	0.00696	CcSEcCtD
Butabarbital—Constipation—Pemetrexed—lung cancer	0.00298	0.00688	CcSEcCtD
Butabarbital—Constipation—Gefitinib—lung cancer	0.00296	0.00683	CcSEcCtD
Butabarbital—Respiratory failure—Docetaxel—lung cancer	0.00291	0.00672	CcSEcCtD
Butabarbital—Hepatocellular injury—Docetaxel—lung cancer	0.00286	0.0066	CcSEcCtD
Butabarbital—Confusional state—Teniposide—lung cancer	0.00285	0.00657	CcSEcCtD
Butabarbital—Body temperature increased—Pemetrexed—lung cancer	0.00276	0.00636	CcSEcCtD
Butabarbital—Body temperature increased—Gefitinib—lung cancer	0.00274	0.00632	CcSEcCtD
Butabarbital—Phenobarbital—ABCC3—lung cancer	0.00271	0.212	CrCbGaD
Butabarbital—Hypotension—Teniposide—lung cancer	0.00264	0.00609	CcSEcCtD
Butabarbital—Dermatitis exfoliative—Paclitaxel—lung cancer	0.0026	0.00599	CcSEcCtD
Butabarbital—Hypersensitivity—Pemetrexed—lung cancer	0.00257	0.00593	CcSEcCtD
Butabarbital—Hypersensitivity—Gefitinib—lung cancer	0.00255	0.00589	CcSEcCtD
Butabarbital—Dizziness—Crizotinib—lung cancer	0.00252	0.00582	CcSEcCtD
Butabarbital—Apnoea—Methotrexate—lung cancer	0.00243	0.00561	CcSEcCtD
Butabarbital—Vomiting—Crizotinib—lung cancer	0.00243	0.0056	CcSEcCtD
Butabarbital—Rash—Crizotinib—lung cancer	0.00241	0.00555	CcSEcCtD
Butabarbital—Dermatitis—Crizotinib—lung cancer	0.0024	0.00554	CcSEcCtD
Butabarbital—Angioedema—Topotecan—lung cancer	0.00234	0.00541	CcSEcCtD
Butabarbital—Amobarbital—CYP2A6—lung cancer	0.00234	0.183	CrCbGaD
Butabarbital—Feeling abnormal—Teniposide—lung cancer	0.00233	0.00537	CcSEcCtD
Butabarbital—Dizziness—Pemetrexed—lung cancer	0.00231	0.00532	CcSEcCtD
Butabarbital—Ataxia—Paclitaxel—lung cancer	0.00231	0.00532	CcSEcCtD
Butabarbital—Syncope—Erlotinib—lung cancer	0.00228	0.00525	CcSEcCtD
Butabarbital—Nausea—Crizotinib—lung cancer	0.00227	0.00523	CcSEcCtD
Butabarbital—Body temperature increased—Teniposide—lung cancer	0.00223	0.00515	CcSEcCtD
Butabarbital—Loss of consciousness—Erlotinib—lung cancer	0.00223	0.00515	CcSEcCtD
Butabarbital—Vomiting—Pemetrexed—lung cancer	0.00222	0.00511	CcSEcCtD
Butabarbital—Vomiting—Gefitinib—lung cancer	0.0022	0.00508	CcSEcCtD
Butabarbital—Rash—Pemetrexed—lung cancer	0.0022	0.00507	CcSEcCtD
Butabarbital—Dermatitis—Pemetrexed—lung cancer	0.0022	0.00507	CcSEcCtD
Butabarbital—Rash—Gefitinib—lung cancer	0.00219	0.00504	CcSEcCtD
Butabarbital—Dermatitis—Gefitinib—lung cancer	0.00218	0.00503	CcSEcCtD
Butabarbital—Anxiety—Erlotinib—lung cancer	0.00215	0.00497	CcSEcCtD
Butabarbital—Liver injury—Doxorubicin—lung cancer	0.00212	0.0049	CcSEcCtD
Butabarbital—Bradycardia—Irinotecan—lung cancer	0.00212	0.00488	CcSEcCtD
Butabarbital—Respiratory failure—Methotrexate—lung cancer	0.0021	0.00484	CcSEcCtD
Butabarbital—Hypersensitivity—Teniposide—lung cancer	0.00208	0.0048	CcSEcCtD
Butabarbital—Nausea—Pemetrexed—lung cancer	0.00207	0.00478	CcSEcCtD
Butabarbital—Nausea—Gefitinib—lung cancer	0.00206	0.00475	CcSEcCtD
Butabarbital—Shock—Erlotinib—lung cancer	0.00204	0.0047	CcSEcCtD
Butabarbital—Angioedema—Vinorelbine—lung cancer	0.00201	0.00463	CcSEcCtD
Butabarbital—Depressed level of consciousness—Methotrexate—lung cancer	0.00199	0.00459	CcSEcCtD
Butabarbital—Pentobarbital—CYP2A6—lung cancer	0.00196	0.154	CrCbGaD
Butabarbital—Ataxia—Docetaxel—lung cancer	0.00195	0.00451	CcSEcCtD
Butabarbital—Bradycardia—Cisplatin—lung cancer	0.00192	0.00443	CcSEcCtD
Butabarbital—Constipation—Vinblastine—lung cancer	0.00184	0.00425	CcSEcCtD
Butabarbital—Vomiting—Teniposide—lung cancer	0.0018	0.00414	CcSEcCtD
Butabarbital—Constipation—Topotecan—lung cancer	0.00179	0.00413	CcSEcCtD
Butabarbital—Hepatocellular injury—Doxorubicin—lung cancer	0.00179	0.00412	CcSEcCtD
Butabarbital—Rash—Teniposide—lung cancer	0.00178	0.00411	CcSEcCtD
Butabarbital—Dermatitis—Teniposide—lung cancer	0.00178	0.0041	CcSEcCtD
Butabarbital—Feeling abnormal—Vinblastine—lung cancer	0.00178	0.0041	CcSEcCtD
Butabarbital—Constipation—Erlotinib—lung cancer	0.00177	0.00409	CcSEcCtD
Butabarbital—Headache—Teniposide—lung cancer	0.00177	0.00408	CcSEcCtD
Butabarbital—Bradycardia—Paclitaxel—lung cancer	0.00173	0.00398	CcSEcCtD
Butabarbital—Feeling abnormal—Topotecan—lung cancer	0.00173	0.00398	CcSEcCtD
Butabarbital—Thiopental—CYP2E1—lung cancer	0.00168	0.131	CrCbGaD
Butabarbital—Nausea—Teniposide—lung cancer	0.00168	0.00387	CcSEcCtD
Butabarbital—Hypotension—Vinorelbine—lung cancer	0.00167	0.00386	CcSEcCtD
Butabarbital—Body temperature increased—Topotecan—lung cancer	0.00166	0.00382	CcSEcCtD
Butabarbital—Body temperature increased—Erlotinib—lung cancer	0.00164	0.00378	CcSEcCtD
Butabarbital—Syncope—Irinotecan—lung cancer	0.00162	0.00374	CcSEcCtD
Butabarbital—Loss of consciousness—Irinotecan—lung cancer	0.00159	0.00367	CcSEcCtD
Butabarbital—Hypersensitivity—Vinblastine—lung cancer	0.00159	0.00366	CcSEcCtD
Butabarbital—Dermatitis exfoliative—Methotrexate—lung cancer	0.00159	0.00366	CcSEcCtD
Butabarbital—Hypersensitivity—Topotecan—lung cancer	0.00154	0.00356	CcSEcCtD
Butabarbital—Constipation—Vinorelbine—lung cancer	0.00153	0.00353	CcSEcCtD
Butabarbital—Confusional state—Irinotecan—lung cancer	0.00149	0.00344	CcSEcCtD
Butabarbital—Feeling abnormal—Vinorelbine—lung cancer	0.00148	0.0034	CcSEcCtD
Butabarbital—Phenobarbital—CYP2A6—lung cancer	0.00147	0.115	CrCbGaD
Butabarbital—Shock—Irinotecan—lung cancer	0.00145	0.00335	CcSEcCtD
Butabarbital—Tension—Paclitaxel—lung cancer	0.00145	0.00334	CcSEcCtD
Butabarbital—Nervousness—Paclitaxel—lung cancer	0.00143	0.00331	CcSEcCtD
Butabarbital—Dizziness—Vinblastine—lung cancer	0.00143	0.00329	CcSEcCtD
Butabarbital—Body temperature increased—Vinorelbine—lung cancer	0.00142	0.00327	CcSEcCtD
Butabarbital—Ataxia—Methotrexate—lung cancer	0.00141	0.00325	CcSEcCtD
Butabarbital—Anxiety—Cisplatin—lung cancer	0.00139	0.00322	CcSEcCtD
Butabarbital—Dizziness—Topotecan—lung cancer	0.00138	0.00319	CcSEcCtD
Butabarbital—Hypotension—Irinotecan—lung cancer	0.00138	0.00318	CcSEcCtD
Butabarbital—Dermatitis exfoliative—Doxorubicin—lung cancer	0.00137	0.00317	CcSEcCtD
Butabarbital—Vomiting—Vinblastine—lung cancer	0.00137	0.00316	CcSEcCtD
Butabarbital—Dizziness—Erlotinib—lung cancer	0.00137	0.00316	CcSEcCtD
Butabarbital—Agitation—Paclitaxel—lung cancer	0.00136	0.00313	CcSEcCtD
Butabarbital—Headache—Vinblastine—lung cancer	0.00135	0.00311	CcSEcCtD
Butabarbital—Angioedema—Paclitaxel—lung cancer	0.00135	0.00311	CcSEcCtD
Butabarbital—Hypotension—Gemcitabine—lung cancer	0.00134	0.0031	CcSEcCtD
Butabarbital—Vomiting—Topotecan—lung cancer	0.00133	0.00307	CcSEcCtD
Butabarbital—Syncope—Paclitaxel—lung cancer	0.00132	0.00305	CcSEcCtD
Butabarbital—Loss of consciousness—Etoposide—lung cancer	0.00132	0.00305	CcSEcCtD
Butabarbital—Rash—Topotecan—lung cancer	0.00132	0.00304	CcSEcCtD
Butabarbital—Hypersensitivity—Vinorelbine—lung cancer	0.00132	0.00304	CcSEcCtD
Butabarbital—Dermatitis—Topotecan—lung cancer	0.00132	0.00304	CcSEcCtD
Butabarbital—Vomiting—Erlotinib—lung cancer	0.00132	0.00304	CcSEcCtD
Butabarbital—Somnolence—Irinotecan—lung cancer	0.00131	0.00303	CcSEcCtD
Butabarbital—Headache—Topotecan—lung cancer	0.00131	0.00303	CcSEcCtD
Butabarbital—Rash—Erlotinib—lung cancer	0.00131	0.00301	CcSEcCtD
Butabarbital—Dermatitis—Erlotinib—lung cancer	0.00131	0.00301	CcSEcCtD
Butabarbital—Headache—Erlotinib—lung cancer	0.0013	0.00299	CcSEcCtD
Butabarbital—Loss of consciousness—Paclitaxel—lung cancer	0.0013	0.00299	CcSEcCtD
Butabarbital—Nausea—Vinblastine—lung cancer	0.00128	0.00295	CcSEcCtD
Butabarbital—Somnolence—Gemcitabine—lung cancer	0.00128	0.00295	CcSEcCtD
Butabarbital—Constipation—Irinotecan—lung cancer	0.00126	0.00291	CcSEcCtD
Butabarbital—Hypotension—Cisplatin—lung cancer	0.00125	0.00289	CcSEcCtD
Butabarbital—Anxiety—Paclitaxel—lung cancer	0.00125	0.00289	CcSEcCtD
Butabarbital—Nausea—Topotecan—lung cancer	0.00124	0.00287	CcSEcCtD
Butabarbital—Confusional state—Etoposide—lung cancer	0.00124	0.00286	CcSEcCtD
Butabarbital—Constipation—Gemcitabine—lung cancer	0.00123	0.00284	CcSEcCtD
Butabarbital—Nausea—Erlotinib—lung cancer	0.00123	0.00284	CcSEcCtD
Butabarbital—Ataxia—Doxorubicin—lung cancer	0.00122	0.00281	CcSEcCtD
Butabarbital—Feeling abnormal—Irinotecan—lung cancer	0.00122	0.00281	CcSEcCtD
Butabarbital—Confusional state—Paclitaxel—lung cancer	0.00121	0.0028	CcSEcCtD
Butabarbital—Feeling abnormal—Gemcitabine—lung cancer	0.00119	0.00273	CcSEcCtD
Butabarbital—Shock—Paclitaxel—lung cancer	0.00119	0.00273	CcSEcCtD
Butabarbital—Dizziness—Vinorelbine—lung cancer	0.00118	0.00273	CcSEcCtD
Butabarbital—Body temperature increased—Irinotecan—lung cancer	0.00117	0.00269	CcSEcCtD
Butabarbital—Hypotension—Etoposide—lung cancer	0.00115	0.00265	CcSEcCtD
Butabarbital—Vomiting—Vinorelbine—lung cancer	0.00114	0.00263	CcSEcCtD
Butabarbital—Body temperature increased—Gemcitabine—lung cancer	0.00114	0.00262	CcSEcCtD
Butabarbital—Rash—Vinorelbine—lung cancer	0.00113	0.0026	CcSEcCtD
Butabarbital—Dermatitis—Vinorelbine—lung cancer	0.00113	0.0026	CcSEcCtD
Butabarbital—Hypotension—Paclitaxel—lung cancer	0.00113	0.0026	CcSEcCtD
Butabarbital—Headache—Vinorelbine—lung cancer	0.00112	0.00259	CcSEcCtD
Butabarbital—Syncope—Docetaxel—lung cancer	0.00112	0.00259	CcSEcCtD
Butabarbital—Feeling abnormal—Cisplatin—lung cancer	0.00111	0.00255	CcSEcCtD
Butabarbital—Loss of consciousness—Docetaxel—lung cancer	0.0011	0.00254	CcSEcCtD
Butabarbital—Somnolence—Etoposide—lung cancer	0.00109	0.00252	CcSEcCtD
Butabarbital—Hypersensitivity—Irinotecan—lung cancer	0.00109	0.00251	CcSEcCtD
Butabarbital—Somnolence—Paclitaxel—lung cancer	0.00107	0.00247	CcSEcCtD
Butabarbital—Nausea—Vinorelbine—lung cancer	0.00106	0.00245	CcSEcCtD
Butabarbital—Body temperature increased—Cisplatin—lung cancer	0.00106	0.00245	CcSEcCtD
Butabarbital—Constipation—Etoposide—lung cancer	0.00105	0.00242	CcSEcCtD
Butabarbital—Phenobarbital—CYP2E1—lung cancer	0.00105	0.0817	CrCbGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—CHRNA3—lung cancer	0.00104	0.00187	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—lung cancer	0.00104	0.00187	CbGpPWpGaD
Butabarbital—Phenobarbital—CYP1A1—lung cancer	0.00103	0.0806	CrCbGaD
Butabarbital—Constipation—Paclitaxel—lung cancer	0.00103	0.00238	CcSEcCtD
Butabarbital—Confusional state—Docetaxel—lung cancer	0.00103	0.00237	CcSEcCtD
Butabarbital—GABRB2—Transmission across Chemical Synapses—CHRNB4—lung cancer	0.00103	0.00185	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—CHRNB4—lung cancer	0.00102	0.00184	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—lung cancer	0.00102	0.00183	CbGpPWpGaD
Butabarbital—Feeling abnormal—Etoposide—lung cancer	0.00101	0.00234	CcSEcCtD
Butabarbital—GABRA1—Transmission across Chemical Synapses—GRIK3—lung cancer	0.00101	0.00182	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—CHRNA3—lung cancer	0.001	0.00182	CbGpPWpGaD
Butabarbital—Shock—Docetaxel—lung cancer	0.001	0.00232	CcSEcCtD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—CHRNB4—lung cancer	0.001	0.00181	CbGpPWpGaD
Butabarbital—Feeling abnormal—Paclitaxel—lung cancer	0.000993	0.00229	CcSEcCtD
Butabarbital—Hypersensitivity—Cisplatin—lung cancer	0.000988	0.00228	CcSEcCtD
Butabarbital—GRIK2—Neuronal System—GNG11—lung cancer	0.000982	0.00177	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—GNG11—lung cancer	0.00098	0.00177	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG11—lung cancer	0.000979	0.00177	CbGpPWpGaD
Butabarbital—Dizziness—Irinotecan—lung cancer	0.000977	0.00225	CcSEcCtD
Butabarbital—GRIA2—Neuronal System—CHRNA5—lung cancer	0.000974	0.00176	CbGpPWpGaD
Butabarbital—Body temperature increased—Etoposide—lung cancer	0.000971	0.00224	CcSEcCtD
Butabarbital—GRIA2—Hypothetical Network for Drug Addiction—MAPK3—lung cancer	0.000971	0.00175	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—TF—lung cancer	0.000969	0.00175	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—GRIK3—lung cancer	0.000965	0.00174	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—CHRNA5—lung cancer	0.000955	0.00172	CbGpPWpGaD
Butabarbital—Hypotension—Docetaxel—lung cancer	0.000954	0.0022	CcSEcCtD
Butabarbital—Body temperature increased—Paclitaxel—lung cancer	0.000952	0.0022	CcSEcCtD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—GNG11—lung cancer	0.00095	0.00172	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—lung cancer	0.000947	0.00171	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—CHRNA5—lung cancer	0.000944	0.00171	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—CHRNA3—lung cancer	0.000944	0.00171	CbGpPWpGaD
Butabarbital—Vomiting—Irinotecan—lung cancer	0.000939	0.00217	CcSEcCtD
Butabarbital—GABRG2—Transmission across Chemical Synapses—CHRNB4—lung cancer	0.000939	0.0017	CbGpPWpGaD
Butabarbital—Rash—Irinotecan—lung cancer	0.000931	0.00215	CcSEcCtD
Butabarbital—Dermatitis—Irinotecan—lung cancer	0.000931	0.00215	CcSEcCtD
Butabarbital—Headache—Irinotecan—lung cancer	0.000925	0.00213	CcSEcCtD
Butabarbital—Vomiting—Gemcitabine—lung cancer	0.000915	0.00211	CcSEcCtD
Butabarbital—Bradycardia—Doxorubicin—lung cancer	0.000913	0.00211	CcSEcCtD
Butabarbital—Somnolence—Docetaxel—lung cancer	0.000908	0.00209	CcSEcCtD
Butabarbital—Rash—Gemcitabine—lung cancer	0.000907	0.00209	CcSEcCtD
Butabarbital—Dermatitis—Gemcitabine—lung cancer	0.000907	0.00209	CcSEcCtD
Butabarbital—Hypersensitivity—Etoposide—lung cancer	0.000905	0.00209	CcSEcCtD
Butabarbital—Headache—Gemcitabine—lung cancer	0.000902	0.00208	CcSEcCtD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG11—lung cancer	0.000895	0.00162	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—GNG11—lung cancer	0.000893	0.00161	CbGpPWpGaD
Butabarbital—Hypersensitivity—Paclitaxel—lung cancer	0.000888	0.00205	CcSEcCtD
Butabarbital—GRIK2—Neuronal System—ADCY1—lung cancer	0.000883	0.00159	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—GRIK3—lung cancer	0.000883	0.00159	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—ADCY1—lung cancer	0.000881	0.00159	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY1—lung cancer	0.00088	0.00159	CbGpPWpGaD
Butabarbital—Nausea—Irinotecan—lung cancer	0.000878	0.00202	CcSEcCtD
Butabarbital—Constipation—Docetaxel—lung cancer	0.000873	0.00201	CcSEcCtD
Butabarbital—GABRG2—Transmission across Chemical Synapses—CHRNA5—lung cancer	0.000873	0.00158	CbGpPWpGaD
Butabarbital—Nausea—Gemcitabine—lung cancer	0.000855	0.00197	CcSEcCtD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—ADCY1—lung cancer	0.000854	0.00154	CbGpPWpGaD
Butabarbital—Vomiting—Cisplatin—lung cancer	0.000853	0.00197	CcSEcCtD
Butabarbital—Rash—Cisplatin—lung cancer	0.000846	0.00195	CcSEcCtD
Butabarbital—Dermatitis—Cisplatin—lung cancer	0.000845	0.00195	CcSEcCtD
Butabarbital—Feeling abnormal—Docetaxel—lung cancer	0.000842	0.00194	CcSEcCtD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—lung cancer	0.000828	0.00149	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—AVP—lung cancer	0.000824	0.00149	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—CHRNB4—lung cancer	0.000821	0.00148	CbGpPWpGaD
Butabarbital—Dizziness—Etoposide—lung cancer	0.000813	0.00187	CcSEcCtD
Butabarbital—Body temperature increased—Docetaxel—lung cancer	0.000807	0.00186	CcSEcCtD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY1—lung cancer	0.000805	0.00145	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—ADCY1—lung cancer	0.000803	0.00145	CbGpPWpGaD
Butabarbital—Dizziness—Paclitaxel—lung cancer	0.000797	0.00184	CcSEcCtD
Butabarbital—Nausea—Cisplatin—lung cancer	0.000797	0.00184	CcSEcCtD
Butabarbital—GRIA2—Neuronal System—CHRNA3—lung cancer	0.000794	0.00143	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—FOXO3—lung cancer	0.000788	0.00142	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—CHRNB4—lung cancer	0.000787	0.00142	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG11—lung cancer	0.000783	0.00141	CbGpPWpGaD
Butabarbital—Vomiting—Etoposide—lung cancer	0.000781	0.0018	CcSEcCtD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—HES1—lung cancer	0.000779	0.00141	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—CHRNA3—lung cancer	0.000778	0.00141	CbGpPWpGaD
Butabarbital—Rash—Etoposide—lung cancer	0.000775	0.00179	CcSEcCtD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—IL10—lung cancer	0.000775	0.0014	CbGpPWpGaD
Butabarbital—Dermatitis—Etoposide—lung cancer	0.000774	0.00179	CcSEcCtD
Butabarbital—GABRA1—Neuronal System—GRIK3—lung cancer	0.000772	0.00139	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—CHRNA3—lung cancer	0.00077	0.00139	CbGpPWpGaD
Butabarbital—Headache—Etoposide—lung cancer	0.00077	0.00178	CcSEcCtD
Butabarbital—Tension—Doxorubicin—lung cancer	0.000766	0.00177	CcSEcCtD
Butabarbital—Vomiting—Paclitaxel—lung cancer	0.000766	0.00177	CcSEcCtD
Butabarbital—GABRA1—Transmission across Chemical Synapses—CHRNA5—lung cancer	0.000763	0.00138	CbGpPWpGaD
Butabarbital—Rash—Paclitaxel—lung cancer	0.00076	0.00175	CcSEcCtD
Butabarbital—Dermatitis—Paclitaxel—lung cancer	0.000759	0.00175	CcSEcCtD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—FOXM1—lung cancer	0.000759	0.00137	CbGpPWpGaD
Butabarbital—Nervousness—Doxorubicin—lung cancer	0.000758	0.00175	CcSEcCtD
Butabarbital—Headache—Paclitaxel—lung cancer	0.000755	0.00174	CcSEcCtD
Butabarbital—Hypersensitivity—Docetaxel—lung cancer	0.000752	0.00174	CcSEcCtD
Butabarbital—GRIA2—Neuronal System—GNG11—lung cancer	0.000751	0.00136	CbGpPWpGaD
Butabarbital—Confusional state—Methotrexate—lung cancer	0.000742	0.00171	CcSEcCtD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000737	0.00133	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—GNG11—lung cancer	0.000736	0.00133	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—CHRNA5—lung cancer	0.000731	0.00132	CbGpPWpGaD
Butabarbital—Nausea—Etoposide—lung cancer	0.00073	0.00168	CcSEcCtD
Butabarbital—GRIA2—N-cadherin signaling events—PIK3CA—lung cancer	0.00073	0.00132	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—GNG11—lung cancer	0.000728	0.00132	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—CHRNB4—lung cancer	0.00072	0.0013	CbGpPWpGaD
Butabarbital—Agitation—Doxorubicin—lung cancer	0.000718	0.00166	CcSEcCtD
Butabarbital—Nausea—Paclitaxel—lung cancer	0.000716	0.00165	CcSEcCtD
Butabarbital—GABRG2—Transmission across Chemical Synapses—CHRNA3—lung cancer	0.000712	0.00129	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—SOX2—lung cancer	0.000706	0.00127	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY1—lung cancer	0.000704	0.00127	CbGpPWpGaD
Butabarbital—Syncope—Doxorubicin—lung cancer	0.0007	0.00162	CcSEcCtD
Butabarbital—Hypotension—Methotrexate—lung cancer	0.000688	0.00159	CcSEcCtD
Butabarbital—Loss of consciousness—Doxorubicin—lung cancer	0.000686	0.00158	CcSEcCtD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—ALDOA—lung cancer	0.000683	0.00123	CbGpPWpGaD
Butabarbital—Dizziness—Docetaxel—lung cancer	0.000675	0.00156	CcSEcCtD
Butabarbital—GRIA2—Neuronal System—ADCY1—lung cancer	0.000675	0.00122	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000674	0.00122	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—GNG11—lung cancer	0.000673	0.00122	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—AVP—lung cancer	0.000672	0.00121	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—CHRNA5—lung cancer	0.000669	0.00121	CbGpPWpGaD
Butabarbital—Anxiety—Doxorubicin—lung cancer	0.000663	0.00153	CcSEcCtD
Butabarbital—GABRB2—Transmission across Chemical Synapses—ADCY1—lung cancer	0.000662	0.0012	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—ADCY1—lung cancer	0.000655	0.00118	CbGpPWpGaD
Butabarbital—Somnolence—Methotrexate—lung cancer	0.000654	0.00151	CcSEcCtD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.000653	0.00118	CbGpPWpGaD
Butabarbital—Vomiting—Docetaxel—lung cancer	0.000649	0.0015	CcSEcCtD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.000648	0.00117	CbGpPWpGaD
Butabarbital—Rash—Docetaxel—lung cancer	0.000644	0.00148	CcSEcCtD
Butabarbital—Dermatitis—Docetaxel—lung cancer	0.000643	0.00148	CcSEcCtD
Butabarbital—Confusional state—Doxorubicin—lung cancer	0.000643	0.00148	CcSEcCtD
Butabarbital—Headache—Docetaxel—lung cancer	0.00064	0.00148	CcSEcCtD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—HES1—lung cancer	0.000635	0.00115	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—IL10—lung cancer	0.000632	0.00114	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—CHRNB4—lung cancer	0.000629	0.00114	CbGpPWpGaD
Butabarbital—Shock—Doxorubicin—lung cancer	0.000627	0.00145	CcSEcCtD
Butabarbital—GABRA1—Transmission across Chemical Synapses—CHRNA3—lung cancer	0.000622	0.00112	CbGpPWpGaD
Butabarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—lung cancer	0.000609	0.0011	CbGpPWpGaD
Butabarbital—Nausea—Docetaxel—lung cancer	0.000607	0.0014	CcSEcCtD
Butabarbital—Feeling abnormal—Methotrexate—lung cancer	0.000607	0.0014	CcSEcCtD
Butabarbital—GABRG2—Transmission across Chemical Synapses—ADCY1—lung cancer	0.000605	0.00109	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—TF—lung cancer	0.0006	0.00108	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—CHRNA3—lung cancer	0.000596	0.00108	CbGpPWpGaD
Butabarbital—Hypotension—Doxorubicin—lung cancer	0.000596	0.00137	CcSEcCtD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.00059	0.00107	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000589	0.00106	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—GNG11—lung cancer	0.000588	0.00106	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—CHRNA5—lung cancer	0.000585	0.00106	CbGpPWpGaD
Butabarbital—Body temperature increased—Methotrexate—lung cancer	0.000582	0.00134	CcSEcCtD
Butabarbital—Somnolence—Doxorubicin—lung cancer	0.000567	0.00131	CcSEcCtD
Butabarbital—GABRB2—Neuronal System—GNG11—lung cancer	0.000564	0.00102	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000558	0.00101	CbGpPWpGaD
Butabarbital—Phenobarbital—ABCB1—lung cancer	0.000548	0.0428	CrCbGaD
Butabarbital—GABRG2—Neuronal System—CHRNA3—lung cancer	0.000545	0.000985	CbGpPWpGaD
Butabarbital—Constipation—Doxorubicin—lung cancer	0.000545	0.00126	CcSEcCtD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.000543	0.000981	CbGpPWpGaD
Butabarbital—Hypersensitivity—Methotrexate—lung cancer	0.000542	0.00125	CcSEcCtD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000541	0.000977	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—IL6R—lung cancer	0.000534	0.000965	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.000533	0.000963	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.000532	0.000961	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—ADCY1—lung cancer	0.000529	0.000956	CbGpPWpGaD
Butabarbital—Feeling abnormal—Doxorubicin—lung cancer	0.000525	0.00121	CcSEcCtD
Butabarbital—GABRG2—Neuronal System—GNG11—lung cancer	0.000516	0.000932	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—APC—lung cancer	0.000515	0.000931	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000511	0.000922	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—ADCY1—lung cancer	0.000507	0.000916	CbGpPWpGaD
Butabarbital—Body temperature increased—Doxorubicin—lung cancer	0.000504	0.00116	CcSEcCtD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.000496	0.000895	CbGpPWpGaD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.000494	0.000892	CbGpPWpGaD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000492	0.000889	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—BRAF—lung cancer	0.000487	0.00088	CbGpPWpGaD
Butabarbital—Dizziness—Methotrexate—lung cancer	0.000487	0.00112	CcSEcCtD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.000481	0.000868	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—CHRNA3—lung cancer	0.000477	0.000861	CbGpPWpGaD
Butabarbital—Hypersensitivity—Doxorubicin—lung cancer	0.00047	0.00108	CcSEcCtD
Butabarbital—Vomiting—Methotrexate—lung cancer	0.000468	0.00108	CcSEcCtD
Butabarbital—GABRB2—Orphan transporters—CREBBP—lung cancer	0.000466	0.000841	CbGpPWpGaD
Butabarbital—Rash—Methotrexate—lung cancer	0.000464	0.00107	CcSEcCtD
Butabarbital—GABRG2—Neuronal System—ADCY1—lung cancer	0.000464	0.000838	CbGpPWpGaD
Butabarbital—Dermatitis—Methotrexate—lung cancer	0.000464	0.00107	CcSEcCtD
Butabarbital—Headache—Methotrexate—lung cancer	0.000461	0.00106	CcSEcCtD
Butabarbital—GRIA2—BDNF signaling pathway—MAP2K1—lung cancer	0.000456	0.000824	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—GNG11—lung cancer	0.000451	0.000814	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000446	0.000806	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—BRAF—lung cancer	0.000443	0.000801	CbGpPWpGaD
Butabarbital—Nausea—Methotrexate—lung cancer	0.000437	0.00101	CcSEcCtD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—IL6R—lung cancer	0.000435	0.000787	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.000435	0.000785	CbGpPWpGaD
Butabarbital—GABRG2—Orphan transporters—CREBBP—lung cancer	0.000426	0.000769	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000424	0.000765	CbGpPWpGaD
Butabarbital—Dizziness—Doxorubicin—lung cancer	0.000421	0.000972	CcSEcCtD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—AVP—lung cancer	0.000416	0.000751	CbGpPWpGaD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.000415	0.00075	CbGpPWpGaD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000414	0.000747	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—MDM2—lung cancer	0.000408	0.000737	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—RAF1—lung cancer	0.000407	0.000735	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000405	0.000732	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—ADCY1—lung cancer	0.000405	0.000732	CbGpPWpGaD
Butabarbital—Vomiting—Doxorubicin—lung cancer	0.000405	0.000935	CcSEcCtD
Butabarbital—GRIA2—BDNF signaling pathway—RAF1—lung cancer	0.000405	0.000731	CbGpPWpGaD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.000403	0.000727	CbGpPWpGaD
Butabarbital—Rash—Doxorubicin—lung cancer	0.000402	0.000927	CcSEcCtD
Butabarbital—Dermatitis—Doxorubicin—lung cancer	0.000401	0.000926	CcSEcCtD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000401	0.000725	CbGpPWpGaD
Butabarbital—Headache—Doxorubicin—lung cancer	0.000399	0.000921	CcSEcCtD
Butabarbital—GRIA2—BDNF signaling pathway—MTOR—lung cancer	0.000395	0.000713	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—JUN—lung cancer	0.000394	0.000711	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—HES1—lung cancer	0.000393	0.00071	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—IL10—lung cancer	0.000391	0.000706	CbGpPWpGaD
Butabarbital—Nausea—Doxorubicin—lung cancer	0.000379	0.000873	CcSEcCtD
Butabarbital—GRIK2—Neuronal System—BRAF—lung cancer	0.000373	0.000674	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—BRAF—lung cancer	0.000373	0.000673	CbGpPWpGaD
Butabarbital—GABRA1—Orphan transporters—CREBBP—lung cancer	0.000372	0.000673	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.000372	0.000672	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—MDM2—lung cancer	0.000371	0.000671	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—RAF1—lung cancer	0.00037	0.000668	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—CASP3—lung cancer	0.000363	0.000656	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—EP300—lung cancer	0.000363	0.000656	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—BRAF—lung cancer	0.000361	0.000653	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—JUN—lung cancer	0.000353	0.000637	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000345	0.000624	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000344	0.000621	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.00034	0.000615	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—BRAF—lung cancer	0.00034	0.000613	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000334	0.000604	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—CASP3—lung cancer	0.00033	0.000597	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.00033	0.000595	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—JUN—lung cancer	0.000321	0.00058	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—SRC—lung cancer	0.000317	0.000572	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—MDM2—lung cancer	0.000313	0.000565	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—MDM2—lung cancer	0.000312	0.000564	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.000312	0.000563	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—RAF1—lung cancer	0.000312	0.000563	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—RAF1—lung cancer	0.000311	0.000562	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000311	0.000561	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000306	0.000552	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—STAT3—lung cancer	0.000305	0.000551	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—GNG11—lung cancer	0.000303	0.000548	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—MDM2—lung cancer	0.000303	0.000547	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—RAF1—lung cancer	0.000302	0.000545	CbGpPWpGaD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000298	0.000538	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.000298	0.000538	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—EP300—lung cancer	0.000296	0.000535	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—MAPK3—lung cancer	0.000292	0.000527	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—BRAF—lung cancer	0.000285	0.000516	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.000285	0.000515	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—MDM2—lung cancer	0.000285	0.000514	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000284	0.000513	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—RAF1—lung cancer	0.000284	0.000512	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.00028	0.000507	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—BRAF—lung cancer	0.00028	0.000505	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—GNG11—lung cancer	0.000277	0.000501	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—BRAF—lung cancer	0.000277	0.0005	CbGpPWpGaD
Butabarbital—GABRB2—Ion channel transport—RAF1—lung cancer	0.000277	0.0005	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000273	0.000492	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000273	0.000492	CbGpPWpGaD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000271	0.00049	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—IL6R—lung cancer	0.00027	0.000487	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.000269	0.000486	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000267	0.000483	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—BRAF—lung cancer	0.000256	0.000462	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—TF—lung cancer	0.000253	0.000458	CbGpPWpGaD
Butabarbital—GABRG2—Ion channel transport—RAF1—lung cancer	0.000253	0.000457	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000249	0.00045	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000249	0.00045	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.000249	0.00045	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000248	0.000449	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—GNG11—lung cancer	0.000242	0.000438	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—MDM2—lung cancer	0.000239	0.000432	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—RAF1—lung cancer	0.000238	0.000431	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—lung cancer	0.000238	0.00043	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—MDM2—lung cancer	0.000234	0.000423	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—RAF1—lung cancer	0.000234	0.000422	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—MDM2—lung cancer	0.000232	0.000419	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—TF—lung cancer	0.000232	0.000419	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—RAF1—lung cancer	0.000231	0.000418	CbGpPWpGaD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000228	0.000412	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—HRAS—lung cancer	0.000224	0.000405	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—BRAF—lung cancer	0.000224	0.000404	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—HRAS—lung cancer	0.000223	0.000402	CbGpPWpGaD
Butabarbital—GABRA1—Ion channel transport—RAF1—lung cancer	0.000221	0.000399	CbGpPWpGaD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000221	0.000399	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000218	0.000394	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000218	0.000394	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—MDM2—lung cancer	0.000214	0.000387	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—BRAF—lung cancer	0.000214	0.000387	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000214	0.000386	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—RAF1—lung cancer	0.000214	0.000386	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000205	0.00037	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—HRAS—lung cancer	0.000204	0.000368	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—TF—lung cancer	0.000203	0.000366	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—JUN—lung cancer	0.000199	0.000359	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—AKT1—lung cancer	0.000197	0.000355	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—BRAF—lung cancer	0.000196	0.000354	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—lung cancer	0.000194	0.00035	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—MDM2—lung cancer	0.000187	0.000339	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—RAF1—lung cancer	0.000187	0.000337	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—EP300—lung cancer	0.000183	0.000331	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—MDM2—lung cancer	0.00018	0.000324	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—RAF1—lung cancer	0.000179	0.000323	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—AVP—lung cancer	0.000176	0.000317	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000174	0.000314	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—HRAS—lung cancer	0.000172	0.00031	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—BRAF—lung cancer	0.000171	0.00031	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—HRAS—lung cancer	0.000171	0.000309	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000171	0.000309	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ABCB1—lung cancer	0.00017	0.000307	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—HRAS—lung cancer	0.000166	0.0003	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—MDM2—lung cancer	0.000164	0.000297	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—RAF1—lung cancer	0.000164	0.000296	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—AVP—lung cancer	0.000161	0.00029	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000157	0.000283	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—HRAS—lung cancer	0.000156	0.000282	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000156	0.000281	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—MDM2—lung cancer	0.000144	0.000259	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—RAF1—lung cancer	0.000143	0.000259	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—AVP—lung cancer	0.00014	0.000254	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000137	0.000247	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000136	0.000246	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—APOA1—lung cancer	0.000134	0.000243	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—HRAS—lung cancer	0.000131	0.000237	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—HRAS—lung cancer	0.000129	0.000232	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—HRAS—lung cancer	0.000127	0.00023	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—APOA1—lung cancer	0.000123	0.000222	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—IL6—lung cancer	0.00012	0.000217	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—HRAS—lung cancer	0.000118	0.000213	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000114	0.000205	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—APOA1—lung cancer	0.000107	0.000194	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ALB—lung cancer	0.000106	0.000192	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000104	0.000188	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—HRAS—lung cancer	0.000103	0.000186	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—HRAS—lung cancer	9.86e-05	0.000178	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ALB—lung cancer	9.73e-05	0.000176	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—RAF1—lung cancer	9.62e-05	0.000174	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—CREBBP—lung cancer	9.09e-05	0.000164	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—HRAS—lung cancer	9.02e-05	0.000163	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—RAF1—lung cancer	8.8e-05	0.000159	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ALB—lung cancer	8.51e-05	0.000154	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—HRAS—lung cancer	7.88e-05	0.000142	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—RAF1—lung cancer	7.69e-05	0.000139	CbGpPWpGaD
